B · Normal
[Johnson & Johnson’s new pulmonary hypertension drug approved for new indications] On November 5, the official website of the State Food and Drug Administration showed that Johnson & Johnson’s macitentan dispersible tablets were approved for marketing, and the presumed indication is children’s pulmonary hypertension.
Comments